Henrik Krüpper

Henrik Kruepper is a seasoned executive with extensive experience in operational and strategic leadership across various sectors, particularly in the chemical and renewable energy industries. Currently serving as Chief Operating Officer for Drug Substances at Siegfried since September 2023, Henrik previously held the position of Chief Executive Officer and Management Board Member at HCS Group, overseeing marketing, sales, procurement, and technology development from May 2012 to August 2023. Prior roles include managing director at Soltecture GmbH, director of sales at Q-Cells AG, and director of strategic marketing and business development at City Solar AG. Henrik’s career also includes significant positions at Evonik Degussa GmbH and Degussa Corporation, focusing on photovoltaics and site excellence. Educational qualifications include a Dipl.-Ing. in Maschinenbau-Verfahrenstechnik from RWTH Aachen University and a diploma from the Emerging Leaders Program at IMD.